Publications

Hauser, RA, AH Shapira, O Rascol, P Barone, Y Mizuno, L Salin, M Haaksma, N Juhel, and W Poewe. 2010. “Randomized, Double-Blind, Multicenter Evaluation of Pramipexole Extended Release Once Daily in Early Parkinson’s Disease.”. Mov Disord.

Rascol, O, P Barone, RA Hauser, Y Mizuno, W Poewe, AH Schapira, L Salin, M Sohr, and C Debieuvre. 2010. “Efficacy, Safety, and Tolerability of Overnight Switching from Immediate- to Once Daily Extended-Release Pramipexole in Early Parkinson’s Disease.”. Mov Disord.

Colosimo, C, P Martinez-Martin, G Fabbrini, RA Hauser, M Merello, J Miyasaki, W Poewe, et al. 2010. “Task Force Report on Scales to Assess Dyskinesia in Parkinson’s Disease: Critique and Recommendations.”. Mov Disord.

Lew, MF, RA Hauser, HI Hurtig, WG Ondo, J Wojcieszek, T Goren, and CJ Fitzer-Attas. 2010. “Long-Term Efficacy of Rasagiline in Early Parkinson’s Disease.”. Int J Neurosci.

Hersh, BP, NL Earl, RA Hauser, and M Stacy. 2010. “Early Treatment Benefits of Ropinirole Prolonged Release in Parkinson’s Disease Patients With Motor Fluctuations.”. Mov Disord.

Watts, RL, KE Lyons, R Pahwa, K Sethi, M Stern, RA Hauser, W Olanow, AM Gray, B Adams, and NL Earl. 2010. “Onset of Dyskinesia With Adjunct Ropinirole Prolonged-Release or Additional Levodopa in Early Parkinson’s Disease”. Mov Disord.

Bronzova, J, C Sampaio, RA Hauser, AE Lang, O Rascol, A Theeuwes, SV Van De Witte, and G van Scharrenburg. 2010. “Double-Blind Study of Pardoprunox, a New Partial Dopamine Agonist, in Early Parkinson’s Disease”. Mov Disord.

Hauser, RA. 2010. “Early Pharmacologic Treatment in Parkinson’s Disease”. Am J Manag Care.

Lyons, KE, JH Friedman, N Hermanowicz, SH Isaacson, RA Hauser, BP Hersh, DE Silver, et al. 2010. “Orally Disintegrating Selegiline in Parkinson Patients With Dopamine Agonist-Related Adverse Effects”. Clin Neuropharmacol.

Isaacson, SH, and RA Hauser. 2009. “Improving Symptom Control in Early Parkinson’s Disease.”. Ther Adv Neurol Disord.